J Vet Sci.  2014 Dec;15(4):519-528. 10.4142/jvs.2014.15.4.519.

Enhancing effects of serum-rich and cytokine-supplemented culture conditions on developing blastocysts and deriving porcine parthenogenetic embryonic stem cells

Affiliations
  • 1Animal and Plant Quarantine Agency, Anyang 430-757, Korea. virusmania@korea.kr
  • 2College of Veterinary Medicine, Kangwon National University, Chuncheon 200-701, Korea.
  • 3College of Agriculture and Life Sciences, Seoul National University, Seoul 151-742, Korea.
  • 4ATGen Ltd., Seongnam 463-400, Korea.

Abstract

The present study was conducted to develop an effective method for establishment of porcine parthenogenetic embryonic stem cells (ppESCs) from parthenogenetically activated oocyte-derived blastocysts. The addition of 10% fetal bovine serum (FBS) to the medium on the 3rd day of oocyte culturing improved the development of blastocysts, attachment of inner cell masses (ICMs) onto feeder cells, and formation of primitive ppESC colonies. ICM attachment was further enhanced by basic fibroblast growth factor, stem cell factor, and leukemia inhibitory factor. From these attached ICMs, seven ppESC lines were established. ppESC pluripotency was verified by strong enzymatic alkaline phosphatase activity and the expression of pluripotent markers OCT3/4, Nanog, and SSEA4. Moreover, the ppESCs were induced to form an embryoid body and teratoma. Differentiation into three germ layers (ectoderm, mesoderm, and endoderm) was confirmed by the expression of specific markers for the layers and histological analysis. In conclusion, data from the present study suggested that our modified culture conditions using FBS and cytokines are highly useful for improving the generation of pluripotent ppESCs.

Keyword

fetal bovine serum; inner cell mass; parthenogenetic embryonic stem cell; porcine; teratoma

MeSH Terms

Animals
Blastocyst/*cytology
Cell Culture Techniques/*veterinary
*Cell Differentiation
Cytokines/metabolism
Embryonic Stem Cells/*cytology
Parthenogenesis
Pluripotent Stem Cells/*cytology
Swine/*physiology
Cytokines

Figure

  • Fig. 1 Morphology of blastocysts in different developmental stages on the 5th to 7th day of in vitro culture (IVC). (A-C) Blastocysts cultured in fetal bovine serum (FBS) (-) medium. Undeveloped or immature blastocysts are indicated by black arrows. (D-F) Blastocysts cultured in FBS (+) medium. Inner cell masses (ICMs) were positioned on one side of the blastocysts (D, arrowhead). Hatching blastocysts (E, white arrow) and hatched blastocysts (F, asterisks) were also observed. Scale bars = 50 µm.

  • Fig. 2 Morphology of the attached ICMs and ppESC colony. (A) Morphology of representative attached ICMs on the 2nd day after implantation obtained from blastocysts developed in FBS (+) medium. The trophectoderm cells are indicated with a black arrow. ICMs are indicated with a white arrow. (B) Morphology of a representative ICM-derived colony before the first passage. (C) A representative image of the ppESCs at passage 2. Scale bars = 100 µm.

  • Fig. 3 Characterization of ppESC stemness. (A) AP reactivity was observed in ppESC line 1 at passage 18 [ppESC1 (P18)]. (B) mRNA expression of OCT3/4 and Nanog was confirmed by RT-PCR [ppESC1 (P28) and ppESC2 (P33)]. Distilled water (DW) and MEFs were used as negative controls. (C) Protein expression of OCT3/4, Nanog, and SSEA4 in the ppESCs was detected by immunofluorescence (IF) staining [ppESC1 (P31)]. Hoechst was used to stain the nuclei (middle panel). Merged images of Hoechst staining and signals for each stemness marker are shown in the bottom panel. (D) Telomerase activity of the ppESCs was observed. Absorbance greater than 0.2 was considered telomerase-positive. The dotted line indicates the value 0.2. Lysis reagent (LR), synthetic oligonucleotide (SO), heat-treated human embryonic kidney 293 cells (heat 293), and porcine primary keratinocytes (Kera) were used as negative controls. HEK 293 cells (293) were used as a positive control. All experiments were performed in triplicate. ppESC1 and ppESC2: undifferentiated ppESCs [ppESC1 (P21) and ppESC2 (P25)]. ppESC1-D and ppESC2-D: differentiated ppESCs [ppESC1-D (P23) and ppESC2-D (P33)]. Scale bars = 500 µm (A) and 100 µm (C).

  • Fig. 4 Characterization of the ppESC differentiation capacity in vitro. (A) Morphology of a representative EB on the 4th day after differentiation induction [ppESC1 (P23)]. (B) mRNA expression of three germ layer markers (NF-H, BMP-4, and GATA6) in differentiated ppESCs [ppESC1 (P25)] was confirmed by RT-PCR. DW and undifferentiated pPESCs [ppESC1 (P32)] were used as negative controls. (C) The expression of lineage-specific markers (vimentin, desmin, and CK17) was detected in differentiated cells [ppESC1 (P35)] by IF. Scale bars = 100 µm.

  • Fig. 5 Characterization of the ppESC differentiation capacity in vivo. (A) Representative structures of three germ layers were observed in H&E-stained ppESC-derived teratomas [ppESC1 (P17)]. (B) Expression of lineage-specific markers (MAP2, SMA, and CK8-18-19) was detected by IF [ppESC1 (P19) and ppESC2 (P23)]. Scale bars = 100 µm (A) and 50 µm (B).


Reference

1. Bendall SC, Stewart MH, Menendez P, George D, Vijayaragavan K, Werbowetski-Ogilvie T, Ramos-Mejia V, Rouleau A, Yang J, Bossé M, Lajoie G, Bhatia M. IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Nature. 2007; 448:1015–1021.
Article
2. Brevini TAL, Antonini S, Cillo F, Crestan M, Gandolfi F. Porcine embryonic stem cells: facts, challenges and hopes. Theriogenology. 2007; 68:Suppl 1. S206–S213.
Article
3. Brevini TAL, Pennarossa G, Attanasio L, Vanelli A, Gasparrini B, Gandolfi F. Culture conditions and signalling networks promoting the establishment of cell lines from parthenogenetic and biparental pig embryos. Stem Cell Rev. 2010; 6:484–495.
Article
4. Brevini TAL, Vassena R, Francisci C, Gandolfi F. Role of adenosine triphosphate, active mitochondria, and microtubules in the acquisition of developmental competence of parthenogenetically activated pig oocytes. Biol Reprod. 2005; 72:1218–1223.
Article
5. Campbell JM, Lane M, Vassiliev I, Nottle MB. Use of insulin to increase epiblast cell number: towards a new approach for improving ESC isolation from human embryos. Biomed Res Int. 2013; 2013:150901.
Article
6. Dobrinsky JR, Johnson LA, Rath D. Development of a culture medium (BECM-3) for porcine embryos: effects of bovine serum albumin and fetal bovine serum on embryo development. Biol Reprod. 1996; 55:1069–1074.
Article
7. Esteban MA, Peng M, Deli Z, Cai J, Yang J, Xu J, Lai L, Pei D. Porcine induced pluripotent stem cells may bridge the gap between mouse and human iPS. IUBMB Life. 2010; 62:277–282.
Article
8. Ezashi T, Telugu BPVL, Alexenko AP, Sachdev S, Sinha S, Roberts RM. Derivation of induced pluripotent stem cells from pig somatic cells. Proc Natl Acad Sci U S A. 2009; 106:10993–10998.
Article
9. Fangerau H. Can artificial parthenogenesis sidestep ethical pitfalls in human therapeutic cloning? An historical perspective. J Med Ethics. 2005; 31:733–735.
Article
10. Glabowski W. The protective effect of stem cell factor (SCF) on in vitro development of preimplantation mouse embryos. Ann Acad Med Stetin. 2005; 51:83–93.
11. Glabowski W, Wiszniewska B, Kurzawa R. Protective potential of SCF for mice preimplantation embryos cultured in vitro in suboptimal conditions. J Assist Reprod Genet. 2008; 25:395–402.
Article
12. Han MS, Niwa K. Effects of BSA and fetal bovine serum in culture medium on development of rat embryos. J Reprod Dev. 2003; 49:235–242.
Article
13. Hardy K, Spanos S. Growth factor expression and function in the human and mouse preimplantation embryo. J Endocrinol. 2002; 172:221–236.
Article
14. Harvey MB, Kaye PL. Insulin increases the cell number of the inner cell mass and stimulates morphological development of mouse blastocysts in vitro. Development. 1990; 110:963–967.
Article
15. Huppertz B, Herrler A. Regulation of proliferation and apoptosis during development of the preimplantation embryo and the placenta. Birth Defects Res C Embryo Today. 2005; 75:249–261.
Article
16. Jin M, Wu A, Dorzhin S, Yue Q, Ma Y, Liu D. Culture conditions for bovine embryonic stem cell-like cells isolated from blastocysts after external fertilization. Cytotechnology. 2012; 64:379–389.
Article
17. Karja NW, Otoi T, Murakami M, Yuge M, Fahrudin M, Suzuki T. Effect of protein supplementation on development to the hatching and hatched blastocyst stages of cat IVF embryos. Reprod Fertil Dev. 2002; 14:291–296.
Article
18. Kim HS, Son HY, Kim S, Lee GS, Park CH, Kang SK, Lee BC, Hwang WS, Lee CK. Isolation and initial culture of porcine inner cell masses derived from in vitro-produced blastocysts. Zygote. 2007; 15:55–63.
Article
19. Liu K, Ji G, Mao J, Liu M, Wang L, Chen C, Liu L. Generation of porcine-induced pluripotent stem cells by using OCT4 and KLF4 porcine factors. Cell Reprogram. 2012; 14:505–513.
Article
20. Ma SF, Liu XY, Miao DQ, Han ZB, Zhang X, Miao YL, Yanagimachi R, Tan JH. Parthenogenetic activation of mouse oocytes by strontium chloride: a search for the best conditions. Theriogenology. 2005; 64:1142–1157.
Article
21. Michalska AE. Isolation and propagation of mouse embryonic fibroblasts and preparation of mouse embryonic feeder layer cells. Curr Protoc Stem Cell Biol. 2007; Suppl 3. Unit1C.3.1–Unit1C.3.17.
22. Miyoshi K, Taguchi Y, Sendai Y, Hoshi H, Sato E. Establishment of a porcine cell line from in vitro-produced blastocysts and transfer of the cells into enucleated oocytes. Biol Reprod. 2000; 62:1640–1646.
Article
23. Nichols J, Smith A. The origin and identity of embryonic stem cells. Development. 2011; 138:3–8.
Article
24. Park JK, Kim HS, Uh KJ, Choi KH, Kim HM, Lee T, Yang BC, Kim HJ, Ka HH, Kim H, Lee CK. Primed pluripotent cell lines derived from various embryonic origins and somatic cells in pig. PLoS One. 2013; 8:e52481.
Article
25. Piedrahita JA, Anderson GB, BonDurant RH. On the isolation of embryonic stem cells: comparative behavior of murine, porcine and ovine embryos. Theriogenology. 1990; 34:879–901.
Article
26. Price PJ, Gregory EA. Relationship between in vitro growth promotion and biophysical and biochemical properties of the serum supplement. In Vitro. 1982; 18:576–584.
Article
27. Prokhorova TA, Harkness LM, Frandsen U, Ditzel N, Schrøder HD, Burns JS, Kassem M. Teratoma formation by human embryonic stem cells is site dependent and enhanced by the presence of Matrigel. Stem Cells Dev. 2009; 18:47–54.
Article
28. Revazova ES, Turovets NA, Kochetkova OD, Kindarova LB, Kuzmichev LN, Janus JD, Pryzhkova MV. Patient-specific stem cell lines derived from human parthenogenetic blastocysts. Cloning Stem Cells. 2007; 9:432–449.
Article
29. Shirazi A, Bahiraee A, Ahmadi E, Nazari H, Heidari B, Borjian S. The effect of the duration of in vitro maturation (IVM) on parthenogenetic development of ovine oocytes. Avicenna J Med Biotechnol. 2009; 1:181–191.
30. Shiue YL, Liou JF, Shiau JW, Yang JR, Chen YH, Tailiu JJ, Chen LR. In vitro culture period but not the passage number influences the capacity of chimera production of inner cell mass and its deriving cells from porcine embryos. Anim Reprod Sci. 2006; 93:134–143.
Article
31. Son J, Malaweera DB, Lee E, Shin S, Cho J. Development of in vitro produced porcine embryos according to serum types as macromolecule. J Vet Sci. 2013; 14:315–321.
Article
32. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. Embryonic stem cell lines derived from human blastocysts. Science. 1998; 282:1145–1147.
Article
33. Vassiliev I, Vassilieva S, Beebe LFS, Harrison SJ, McIlfatrick SM, Nottle MB. In vitro and in vivo characterization of putative porcine embryonic stem cells. Cell Reprogram. 2010; 12:223–230.
Article
34. Zhang K, Wei HX, Zhang YH, Wang SH, Li Y, Dai YP, Li N. Effects of ghrelin on in vitro development of porcine in vitro fertilized and parthenogenetic embryos. J Reprod Dev. 2007; 53:647–653.
Article
Full Text Links
  • JVS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr